Effect of nicotine and nicotinic receptor agonists on latent inhibition in the rat

Journal of Pharmacology and Experimental Therapeutics

Volumn 277, Issue 3, 1996, Pages 1267-1275

  Rochford, Joseph ^a,b   Sen, Ananda P ^a   Quirion, Rémi ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b Fonds de la Rech en S du Quebec ^*  (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR; CYTISINE; HEXAMETHONIUM; LOBELINE; MECAMYLAMINE; NICOTINE; NICOTINIC AGENT; NICOTINIC RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ARTICLE; COGNITION; CONDITIONED REFLEX; DRUG EFFECT; DRUG SCREENING; EMOTION; INTRAPERITONEAL DRUG ADMINISTRATION; LATENT INHIBITION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TRAINING;

ALKALOIDS; ANIMALS; AZOCINES; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; LOBELINE; MALE; NICOTINE; NICOTINIC AGONISTS; QUINOLIZINES; RATS; RATS, WISTAR; REACTION TIME;

EID: 0030425589     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. ALBERT, M. AND AYRES, J. J. B.: With number of exposures held constant latent inhibition increases with preexposure CS duration or total Cs exposure. Learn. Motiv. 20: 278-294, 1989.
2. ANNAU, Z. AND KAMIN, L. J.: The conditioned emotional response as a function of intensity of the U.S. J. Comp. Physiol. Psychol. 54: 428-432, 1961.
3. 3H]methylcarbamylcholine binding sites and effect of N-methylcarbamylcholine on acetylcholine release in rat brain. J. Neurochem. 51: 292-299, 1988.
4. ASGHAR, K. AND ROTH, L. J.: Entry and distribution of hexamethonium in the central nervous system. Biochem. Pharmacol. 20: 2787-2795, 1971.
5. AYRES, J. J. B., PHILBIN, D., CASSIDY, S., BELLINO, L. AND REDLINGER, E.: Some parameters of latent inhibition. Learn. Motiv. 23: 69-287, 1992.
6. BALFOUR, D. J. K.: The effects of nicotine on brain neurotransmitter systems. Pharmacol. Ther. 16: 269-282, 1982.
7. 3H-acetylcholine release from cortical slices of guinea pig brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 331: 293-304, 1985.
8. BLOZOVSKI, D.: Deficits in passive avoidance learning in young rats following mecamylamine injections in the hippocampo-entorhinal area. Exp. Brain Res. 50: 442-448, 1983.
9. CAVALLITO, C. J.: Quaternary ammonium salts - Advances in chemistry and pharmacology since 1960. Prog. Drug Res. 24: 267-373, 1980.
10. CHIAPPETTA, L. AND JARVIK, M. E.: Comparison of learning impairment and activity depression produced by two classes of cholinergic blocking agents. Arch. Int. Pharmacodyn. Ther. 179: 161-166, 1969.
11. DE LA CASA, L. G., RUIZ, G. AND LUBOW, R. E.: Amphetamine-produced attenuation of latent inhibition is modulated by stimulus preexposure duration: Implications for schizophrenia. Biol. Psychiatry 33: 707-711, 1993.
12. DENERIS, E. S., CONNELLY, J., ROGERS, S. W. AND DUVOISIN, R.: Pharmacological and functional diversity of neuronal nicotinic acetylcholine receptors. Trends Pharmacol. Sci. 12: 34-40, 1991.
13. DE SARNO, P. AND GIACOBINI, E.: Modulation of acetylcholine release by nicotinic receptors in rat brain. J. Neurosci. Res. 22: 194-200, 1989.
14. ELROD, K. AND BUCCAFUSCO, J. J.: Correlation of the amnestic effects of nicotinic antagonists with inhibition of regional brain acetylcholine synthesis in rats. J. Pharmacol. Exp. Ther. 258: 403-409, 1991.
15. EVANGELISTA, A. M., GATTONI, R. C. AND IZQUIERDO, I.: Effects of amphetamine, nicotine and hexamethonium on performance of a conditioned response during acquisition and retention trials. Pharmacology 3: 91-96, 1970.
16. FIBIGER, H. C.: Cholinergic mechanisms in learning, memory and dementia: A review of recent evidence. Trends Neurosci. 14: 220-223, 1991.
17. FREY, P. W. AND SEARS, R. J.: Model of conditioning incorporating the Rescorla-Wagner associative axiom, a dynamic attention process, and a catastrophe rule. Psychol. Rev. 85: 321-340, 1978.
18. GALZI, J. L. REVAH, F., BESSIS, A. AND CHANGEUX, J. P.: Functional architecture of the nicotinic acetylcholine receptor: From electric organ to brain. Annu. Rev. Pharmacol. 31: 37-72, 1991.
19. GLICK, S. D. AND GREENSTEIN, S.: Differential effects of scopolamine and mecamylamine on passive avoidance behavior. Life Sci. 11: 169-172., 1972.
20. HAGAN, J. J. AND MORRIS, R. G. M.: The cholinergic hypothesis of memory: A review of animal experiments. In Psychopharmacology of the Aging Nervous System, ed. by L. L. Iversen, S. D. Iversen and S. H. Snyder, pp. 237-323, Plenum Press, New York, 1988.
21. HASSELMO, M. E. AND BOWER, J. M.: Acetylcholine and memory. Trends Neurosci. 16: 218-222, 1993.
22. IZQUIERDO, I.: Possible peripheral adrenergic and cholinergic mechanisms in pseudoconditioning. Psyehopharmacologia 35: 189-193, 1974.
23. JAMES, W.: The Principles of Psychology, Vol. 1, Henry Holt, New York, 1890.
24. JOSEPH, M. H., PETERS, S. L. AND GRAY, J. A.: Nicotine blocks latent inhibition in rats: Evidence for a critical role of increased functional activity of dopamine in the mesolimbic system at conditioning rather than preexposure. Psychopharmacology 110: 187-192, 1993.
25. KILLCROSS, A. S., DICKINSON, A. AND ROBBINS, T. W.: Amphetamine-induced disruptions of latent inhibition are reinforcer mediated - Implications for animal models of schizophrenic attentional dysfunction. Psychopharmacology 115: 185-195, 1994.
26. KLOWDEN, A. J., IVANKOVICH, A. D. AND MILETICH, D. J.: Ganglionic blocking drugs: General considerations and metabolism. Int. Anesthesiol. Clin. 16: 113-150, 1978.
27. KUMAR, R. J., PRATT, A. AND STOLERMAN, I. P.: Characteristics of conditioned taste aversion produced by nicotine in rats. Br. J. Pharmacol. 79: 245-253, 1983.
28. LUBOW, R. E.: Latent Inhibition and Conditioned Attention Theory, Cambridge University Press, Cambridge, 1989.
29. MACKINTOSH, N. J.: A theory of attention: Variations in the associability of stimuli with reinforcement. Psychiatr. Rev. 82: 276-298, 1975.
30. MARTINEZ, J. L., LIANG, K. C. AND Oscos, A.: Amnesia induced by stimulation of the amygdala is attenuated by hexamethonium. Psychopharmacology 81: 310-314, 1983.
31. MCGAUGH, J. L.: Hormonal influences on memory. Annu. Rev. Psychol. 34: 297-323, 1983.
32. NELSEN, J. M. AND GOLDSTEIN, L.: Improvement of performance on an attention task with chronic nicotine treatment in rats. Psychopharmacologia 26: 347-360, 1972.
33. NELSEN, J. M., PELLEY, K. AND GOLDSTEIN, L.: Protection by nicotine from behavioral disruption caused by reticular formation stimulation in the rat. Pharmacol. Biochem. Behav. 3: 749-754, 1975.
34. PEARCE, J. M. AND HALL, G.: A model for Pavlovian learning: Variations in the effectiveness of conditioned but not unconditioned stimuli. Psychiatr. Rev. 87: 532-552, 1980.
35. REAVILL, C., WALTHER, B., STOLERMAN, I. P. AND TESTA, B.: Behavioral and pharacokinetic studies on nicotine, cytisine and lobeline. Neuropharmacology 29: 619-624, 1990.
36. ROMANO, C., GOLDSTEIN, A. AND JEWELL, N. P.: Characterization of the receptor mediating the nicotine discriminative stimulus. Psychopharmacology 74: 310-315, 1981.
37. 3H]acetylcholine release from mouse cerebral cortical synaptosomes. J. Neurochem. 43: 1593-1598, 1984.
38. RUSH, D. K. AND STREET, K.: Memory modulation with peripherally acting cholinergic drugs. Psychopharmacology 106: 375-382, 1992.
39. SOLOMON, C. R., CRIDER, A., WINKELMAN, J. W., TURI, A., KRAMER, R. M. AND KAPLAN, L. J.: Disrupted latent inhibition in the rat with chronic amphetamine or haloperidol-induced supersensitivity: Relationship to to schizophrenic attention disorder. Biol. Psychiatry 16: 519-538, 1981.
40. SOLOMON, P. R. AND STATON. D. M.: Differential effects of micronijections of d-amphetamine into the nucleus accumbens or the caudate putamen on the ability to ignore an irrelevant stimulus. Biol. Psychiatry 17: 743-756, 1982.
41. STOLERMAN, I. P.: Behavioural pharmacology of nicotine: Multiple mechanisms. Br. J. Addict. 86: 533-536, 1991.
42. TAYLOR, P.: Agents acting at the neuromuscular junction and autonomic ganglia. In The Pharmacological Basis of Therapeutics, 8th ed., ed. by A. Goodman Gilman, T. W. Rail, A. S. Nies and P. Taylor, pp. 166-186, Pergamon, New York, 1990.
43. WAGNER, A. R.: Expectancies and the priming of STM. In Cognitive Processes in Animal Behavior, ed. by S. H. Hulse, H. Fowler and W. K. Honig, pp. 177-209, Erlbaum, Hillsdale, 1978.
44. WAGNER, A. R.: SOP: A model of automatic memory processing in animal behavior. In Information Processing in Animals: Memory mechanisms, ed. by N. E. Spear and R. R. Miller, pp. 5-47, Erlbaum, Hillsdale, 1981.
45. WASSERMAN, O.: Studies on the pharmacokinetics of bis-quaternary compounds. II. Autoradiographic studies on the distribution pattern of 3H-hexamethonium-derivates in mice. Naunyn-Schmiedeberg's Arch. Pharmacol. 270: 419-427, 1971.
46. WEINER, I.: Neural substrates of latent inhibition: The switching model. Psychiatr. Bull. 108: 442-461, 1990.
47. WEINER, I., LUBOW, R. E. AND FELDON, J.: Abolition of the expression but not the acquisition of latent inhibition by chronic amphetamine in rats. Psychopharmacology 83: 194-199, 1984.
48. WEINER, I., LUBOW, R. E. AND FELDON, J.: Disruption of latent inhibition by acute administration of low doses of amphetamine. Pharmacol. Biochem. Behav. 30: 871-878, 1988.
49. WENK, G. L.: An hypothesis on the role of glucose in the mechanism of action of cognitive enhancers. Psychopharmacology 99: 431-438, 1989.
50. WINER, B. J.: Statistical Principles in Experimental Design, 2nd ed., McGraw-Hill, New York, 1971.